Home › Funds › Fairmount Funds Management LLC › COGT

Fairmount Funds Management LLC position in COGT

COGENT BIOSCIENCES INC · Health Care

Fairmount Funds Management LLC reported holding 5,503,418 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$213.0M, representing 14.08% of its reported portfolio and ranking #4 among its reported holdings. Fairmount Funds Management LLC has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)5.50M sh
Reported value held$212.98M
Portfolio Weight14.08%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Fairmount Funds Management LLC's COGT position evolved

Fairmount Funds Management LLC first disclosed a stake in COGT in Q3 2023 at 3,558,975 shares (US$34.7M). The position peaked in Q4 2025 at 9,003,418 shares, worth US$319.8M. Across 12 filings, Fairmount Funds Management LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 5,503,418 shares valued at US$213.0M. Notable position changes include a 33% increase in Q1 2024 (shares rose 25% over the following quarter), a 45% increase in Q3 2025 (shares rose 147% over the following quarter), a 39% trim in Q1 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.56M $34.70M New
Q4 2023 3.56M $20.93M Hold
Q1 2024 4.73M $31.76M Add
Q2 2024 6.23M $52.48M Add
Q3 2024 6.23M $67.24M Hold
Q4 2024 6.23M $48.56M Hold
Q1 2025 6.23M $37.29M Hold
Q2 2025 6.23M $44.70M Hold
Q3 2025 9.00M $129.29M Add
Q4 2025 9.00M $319.80M Hold
Q1 2026 5.50M $211.83M Reduce
Q2 2026 5.50M $212.98M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COGT and 13F data

COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M), Kynam Capital Management, LP (US$141.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COGT

All COGT fund holders →

FAQ

How long has Fairmount Funds Management LLC held COGT?

Fairmount Funds Management LLC has disclosed COGT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Fairmount Funds Management LLC's current position in COGT?

As of Q2 2026, Fairmount Funds Management LLC holds 5.50M shares of COGT (COGENT BIOSCIENCES INC), valued at $212.98M, representing 14.08% of its reported portfolio and ranking #4.

Has Fairmount Funds Management LLC been buying or selling COGT?

In the latest 13F filing (Q2 2026), Fairmount Funds Management LLC held unchanged its position in COGT. The position peaked in Q4 2025 at 9.00M shares.

Which other funds hold COGT?

Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, Kynam Capital Management, LP, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.